South Korea Women's Health Market Size & Outlook
South Korea women's health market, 2018-2030 (US$M)
Related Markets
The increasing prevalence of target diseases, high awareness, and well-established healthcare structure are some of the key factors driving the market in South Korea. The prevalence of osteoporosis in Korean adults aged 50 or above was 35.5% in women and 7.5% in men.
The estimated osteoporosis diagnosis rate was 26.2% (men 5.8% & women 29.9%) and the treatment rate was 12.8%. Global and local pharmaceutical companies and research organizations are adopting different market strategies to improve women’s health in South Korea.
For instance, in June 2020, Daewon Pharmaceutical launched the teriparatide biosimilar Terrosa used for the treatment of osteoporosis in postmenopausal women. Similarly, in December 2023, Zydus Lifesciences Ltd.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women's Health Market Scope
Women's Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea Women's Health Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
